Remote medicine by videophone in patients with pulmonary hypertension

Pulmonary hypertension and Telemedicine -a validity trial - PH-TV trial

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000043222

Enrollment

Registered

2021-03-01

Start date

2020-08-21

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary hypertension

Interventions

Use of telemedicine system including videophone,sphygmomanometer, weight scale, pulse oxmeter, ECG monitor 3 months To See a patient by videophone (once per month,from day 1 to 30 and from day 61 to

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with pulmonary hypertension treated in our hospital (age>=18 years old)

Exclusion criteria

Exclusion criteria: Patients with permanent pacemaker

Design outcomes

Primary

Measure	Time frame
Health related quality of life assessed by SF-36 at baseline,2 months and 3 months after inclusion	—

Secondary

Measure	Time frame
Change in vital signs Clinical events (unexpected hospitalization and death) during study period	—

Countries

Japan

Contacts

Public ContactTatsuo Aoki

National Cerebral Cardiovascular Center Cardiovascular Department

aoki.tatsuo@ncvc.go.jp06-6170-1070

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026